Showing results (651-660 of 744) with videos related to
Sort By:
Pageof 75
Nature|October 2, 2003
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumoursDavid M Berman, Sunil S Karhadkar, Anirban Maitra, et al.American Journal of Clinical Pathology|January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasmsGang Zheng, Guido Martignoni, Cristina Antonescu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
MSH2 Loss in Primary Prostate CancerLiana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, et al.Molecular Diagnosis & Therapy|October 4, 2022
Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer PatientsJoshua D Silvertown, Connie Lisle, Laura Semenuk, et al.The Journal of Pathology|October 29, 2014
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progressionBrian W Simons, Nicholas M Durham, Tullia C Bruno, et al.Science (New York, N.Y.)|August 31, 2002
Medulloblastoma growth inhibition by hedgehog pathway blockadeDavid M Berman, Sunil S Karhadkar, Andrew R Hallahan, et al.Annals of the New York Academy of Sciences|June 19, 2013
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanomaJedd D Wolchok, F Stephen Hodi, Jeffrey S Weber, et al.European Urology Focus|March 27, 2021
International Society of Urological Pathology Expert Opinion on Grading of Urothelial CarcinomaTheo van der Kwast, Fredrik Liedberg, Peter C Black, et al.Human Pathology|April 26, 2017
Pericytic tumors of the kidney-a clinicopathologic analysis of 17 casesDeepika Sirohi, Steven C Smith, Jonathan I Epstein, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomasHsueh-Li Tan, Michael C Haffner, David M Esopi, et al.Pageof 75